- Home
- PACB
as 10-30-2025 4:00pm EST
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.
Upcoming Earnings Alert:
Get ready for potential market movements as Pacific Biosciences of California Inc. PACB prepares to release earnings report on 05 Nov 2025.
| Founded: | 2000 | Country: | United States |
| Employees: | N/A | City: | MENLO PARK |
| Market Cap: | 369.5M | IPO Year: | 2010 |
| Target Price: | $1.90 | AVG Volume (30 days): | 9.5M |
| Analyst Decision: | Buy | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.83 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.85 - $2.72 | Next Earning Date: | 11-05-2025 |
| Revenue: | $156,110,000 | Revenue Growth: | -17.35% |
| Revenue Growth (this year): | 6.06% | Revenue Growth (next year): | 15.15% |
Stock Insider Trading Activity of Pacific Biosciences of California Inc. (PACB)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Van Oene Mark | PACB | See Remarks | Aug 18 '25 | Sell | $1.31 | 26,836 | $35,182.00 | 1,920,035 |
Latest Pacific Biosciences of California Inc. News
PACB Breaking Stock News: Dive into PACB Ticker-Specific Updates for Smart Investing
StockStory
8 days ago
3 Cash-Burning Stocks with Open Questions
GlobeNewswire
8 days ago
PacBio to Report Third Quarter 2025 Financial Results on November 5, 2025
Zacks
9 days ago
Pacific Biosciences of California (PACB) Stock Moves -4.04%: What You Should Know
Zacks
10 days ago
PacBio Aims to Expand Multiomic Capabilities Via Latest Innovations
Simply Wall St.
12 days ago
Pacific Biosciences (PACB): Assessing Valuation After SPRQ-Nx Launch and Landmark Genomics Project Wins
Simply Wall St.
13 days ago
Why Pacific Biosciences (PACB) Is Up 15.0% After Launching Cost-Saving SPRQ-Nx Chemistry and Major Project Wins
Zacks
16 days ago
Pacific Biosciences of California (PACB) Sees a More Significant Dip Than Broader Market: Some Facts to Know
GlobeNewswire
16 days ago
PacBio Announces Major Advances for Revio and Vega to Lower Genome Cost and Expand Multiomic Capabilities
Compare PACB vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PACB Pacific Biosciences of California Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.